Reaction

Congenital Aplasia reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 286 reports · 40 co-occurring drugs

As of the last recalculation, Congenital Aplasia appears in 286 FAERS reports alongside 40 co-occurring drug terms. The strongest observed disproportionality signal is THIOTEPA (PRR 155.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Thiotepa	19	155.0	155.3
Busulfan	30	154.9	155.2
Brentuximab Vedotin	19	144.4	144.7
Fludarabine Phosphate	55	125.8	126.0
Phenobarbital	22	119.6	119.8
Zonisamide	22	117.2	117.3
Posaconazole Delayed-Release	16	112.3	112.4
Azacitidine For	23	100.0	100.1
Cytarabine	59	89.8	89.9
Ifosfamide	24	88.6	88.7
Axicabtagene Ciloleucel	11	84.3	84.4
Canakinumab	12	84.2	84.3
Posaconazole	17	80.9	81.0
Azacitidine	29	79.0	79.1
Phenytoin	21	79.0	79.0
Atovaquone	8	74.4	74.4
Clobazam	22	71.0	71.0
Indomethacin	12	68.8	68.8
Cladribine	8	62.3	62.3
Pegaspargase	10	61.6	61.6
Leucovorin Calcium	15	60.2	60.3
Piperacillin Sodium,Tazobactam Sodium	20	58.9	59.0
Ganciclovir	8	58.5	58.5
Ganciclovir Sodium	8	56.6	56.6
Valganciclovir Hydrochloride Powder,	9	55.4	55.5
Anakinra	12	54.9	54.9
Cyclophosphamide Injection, Solution	85	49.3	49.3
Cyclophosphamide	85	49.3	49.3
Cyclophosphamide For Injection	85	49.3	49.3
Anti-Thymocyte Globulin (Rabbit)	5	45.9	45.9
Etoposide	39	44.5	44.6
Lacosamide	21	44.2	44.3
Venetoclax	33	44.0	44.0
Micafungin Sodium	5	43.7	43.7
Bendamustine Hcl	9	43.6	43.6
Amikacin	9	39.6	39.6
Carboplatin	50	34.5	34.5
Thalidomide	16	33.5	33.6
Doxorubicin	35	32.4	32.4
Bendamustine Hydrochloride	4	24.6	24.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.